Faculty Information - Fang Jun | SOJO UNIVERSITY

（Last updated : 2023-01-31 18:03:03）

Visruth.jpg not found

Fang Jun

Department / Course FACULTY OF PHARMACEUTICAL SCIENCES Department of Pharmaceutical Sciences

Job

Book and thesis
1.	1999	Papers	Circumferential resection and "Z"-shape plastic end-to-end anastomosis of canine trachea Chin Med J (Engl) 112 (3),pp.278-280 (Co-authored)
2.	2002	Papers	Pegylated zinc portoporphyrin: a water-soluble heme oxygenase inhibitor with tumor-targeting capacity Bioconjug Chem 13 (5),pp.1031-1038 (Co-authored)
3.	2002	Papers	Tumor-targeted Delivery of Polyethylene Glycol-conjugated D-Amino Acid Oxidase for Antitumor Therapy via Enzymatic Generation of Hydrogen Peroxide Cancer Res 62 (11),pp.3138-3143 (Co-authored)
4.	2003	Papers	Antiapoptotic effect of haem oxygenase-1 induced by nitric oxide in experimental solid tumour Br J Cancer 88,pp.902-909 (Co-authored)
5.	2003	Papers	Factors and mechanism of EPR effect and the enhanced antitumor effects of macromolecular drugs including SAMNCS Adv Exp Med Biol 519,pp.29-49 (Co-authored)
Display All（114）

Academic conference presentation
1.	2001/07/13	Preparation of poly(ethylene glycol) conjugated D-amino acid oxidase and its antitumor activity based on tumor-targeted delivery and generation of hydrogen peroxide (Intl. Symposium on Polymer Therapeutics)
2.	2002/09/23	Pegylated zinc protoporphyrin for cancer therapy: an antitumor strategy by targeted inhibition of heme oxygenase-1 in solid tumor (2nd Intl. Symposium & Exposition on Tumor Targeted Delivery System (CRS/NCI))
3.	2003/07/20	Oxidation Chemotherapy via Targeted Delivery of Pegylated D-Amino Acid Oxidase and Pegylated Zinc Protoprophyrin Based on EPR Effect (30th Annual Meeting and Exposition of Controlled Release Society)
4.	2004/03/27	The H+-linked monocarboxylate transporter (MCT1/SLC16A1): A potential target in neuroblastoma (95th Annual Meeting of the American Association for Cancer Research)
5.	2004/11/08	The H+-linked monocarboxylate transporter (MCT1/SLC16A1): A potential target in neuroblastoma (International Conference on Tumor progression and Therapeutic Resistance)
Display All（31）

Academic background
1.	1999/04～2003/03	Doctorial Graduate School, Division of Medicine Kumamoto University Finished (Tumor diagnostics and therapeutics)

Business career
1.	2003/09 ～ 2005/03	Research Associate
2.	2005/04/01 ～ 2010/03/31	SOJO UNIVERSITY FACULTY OF PHARMACEUTICAL SCIENCES Department of Pharmaceutical Sciences
3.	2010/04/01 ～	SOJO UNIVERSITY FACULTY OF PHARMACEUTICAL SCIENCES Department of Pharmaceutical Sciences
4.	2012/04/01 ～	/(DC)Division of Pharmaceutical Sciences

Main Subject
Drug Delivery Science, Oncology, Chemotherapeutics, Microbiology, Cell biology

Belonging society
1.		Controlled release Soeiely (CRS)

researchmap Researcher code
B000346537

Research topic, funded research, and department laboratory expense
1.	2013/04 ～ 2016/03	Design of tumor-targeted zinc protoporphyrin micelles for cancer theranostics
2.	2013/04 ～ 2014/03	Development of theranositic drug aiming to the detection and treatment of small tumor Other grants and subsidy
3.	2011/04 ～ 2014/03	Development of macromolecular probe for fluorescence endoscope Other grants and subsidy
4.	2010/04 ～ 2013/03	Photodynamic anticancer therapy by use of macromolecular micelles of zinc protoporphyrin and xenon light
5.	2008/04 ～ 2010/03	Macromolecular anticancer agent, PEGylated Zinc protoporphyrin (ZnP) targeting HSP32
Display All（7）

E-Mail Address

Present specialized field
Others, Others, Applied microbiology , Experimental pathology, Tumor biology keyword(DDS, nanomedicine, tumor-targeting, EPR effect, reactive oxygen species, carbon monoxide)

Department laboratory expense researcher number
20412736